11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

#o

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/12/24 08:01
11/11/24
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic11P30826.820124040D
10/15/24 09:21
10/11/24
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo Diagnostic610P1,29213.5309636364D
10/9/24 13:18
9/6/24
NUTXCardio Diagnostics Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic310P.m1700.32810518115,163D
10/4/24 19:40
10/2/24
OCXOncocyte CorpCAHealthDiagnIn Vitro & In Vivo Diagnostic45P.d11,1452.9303,8064312,611D
8/21/24 08:26
8/20/24
VNRXVolitionrx LtdDEHealthDiagnIn Vitro & In Vivo Diagnostic1120P.m2950.84260350410,021D
7/16/24 21:13
7/12/24
TKNOAlpha Teknova, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic710P.m31,9561.50021,28532427,856D
7/11/24 17:15
9/8/23
AWHAspira Women'S Health Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic1117P.d7262.590280142,235D
3/8/24 11:24
3/6/24
CATXPerspective Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic11P57,4090.9500060,431107116,773D
3/6/24 16:49
3/4/24
ACHVAchieve Life Sciences, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic22P.d924.5902021115D
2/26/24 18:48
2/23/24
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo Diagnostic11P10046.3502546I
8/24/23 17:58
8/24/23
MYMDMymd Pharmaceuticals, Inc.NJHealthDiagnIn Vitro & In Vivo Diagnostic12P1951.11017578400D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact